The fumagillin analogue TNP-470 inhibits DNA synthesis of vascular smooth muscle cells stimulated by platelet-derived growth factor and insulin-like growth factor-I. Possible involvement of cyclin-dependent kinase 2.

The effect of an angiogenesis inhibitor, TNP-470, on DNA synthesis and its underlying signaling cascades stimulated by platelet-derived growth factor (PDGF)-BB and insulin-like growth factor (IGF)-I were examined in bovine vascular smooth muscle cells (SMCs). PDGF-BB (10 ng/mL)- and IGF-I (100 ng/mL)-stimulated increase in DNA synthesis was completely abolished by simultaneous treatment with TNP-470 (1.0 ng/mL). TNP-470 had no effects on PDGF receptor autophosphorylation or early signal transduction, such as activation of mitogen-activated protein kinase and immediate early gene expression. PDGF-BB induced an increase in mRNA levels of cyclin D1, cyclin-dependent kinase (cdk) 4, and cdk2, as well as the activity of cdk2, which preceded the G1/S boundary, as estimated by the kinetics of DNA synthesis. The PDGF-BB-induced activation of cdk2 was inhibited by TNP-470, which was correlated with decreased cdk2 mRNA levels. In contrast, TNP-470 had no or less marked effect on cyclin D1 and cdk4 mRNA levels induced by PDGF-BB. TNP-470 also inhibited a much smaller increase in cdk2 mRNA levels and activation stimulated by IGF-I. In conclusion, TNP-470 potently inhibits DNA synthesis of SMCs, and this inhibition is associated with decreased levels of cdk2 mRNA and activity.

[1]  A. Hansson,et al.  Activation of MAP kinase in Swiss 3T3 fibroblasts by insulin-like growth factor-I. , 1995, Growth regulation.

[2]  S. Marx,et al.  Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. , 1995, Circulation research.

[3]  K. Sudo,et al.  Suppression of cyclin D1 mRNA expression by the angiogenesis inhibitor TNP-470 (AGM-1470) in vascular endothelial cells. , 1994, Biochemical and biophysical research communications.

[4]  W. Zhou,et al.  A fumagillin derivative angiogenesis inhibitor, AGM-1470, inhibits activation of cyclin-dependent kinases and phosphorylation of retinoblastoma gene product but not protein tyrosyl phosphorylation or protooncogene expression in vascular endothelial cells. , 1994, Cancer research.

[5]  H. Koyama,et al.  Protein kinase C is involved in 24‐hydroxylase gene expression induced by 1,25(OH)2D3 in rat intestinal epithelial cells , 1994, Journal of cellular biochemistry.

[6]  V. Castronovo,et al.  AGM-1470, a potent angiogenesis inhibitor, prevents the entry of normal but not transformed endothelial cells into the G1 phase of the cell cycle. , 1994, Cancer research.

[7]  C. Pepine,et al.  Localization of insulin-like growth factor I and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells. A potential treatment for restenosis? , 1994, Circulation.

[8]  R. Furlanetto,et al.  Insulin-like growth factor-I induces cyclin-D1 expression in MG63 human osteosarcoma cells in vitro. , 1994, Molecular endocrinology.

[9]  E. Krebs,et al.  Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. , 1994, The Journal of clinical investigation.

[10]  M. Ewen,et al.  TGFβ inhibition of Cdk4 synthesis is linked to cell cycle arrest , 1993, Cell.

[11]  R. Ross,et al.  Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[12]  P. Howe,et al.  Transforming growth factor β1‐mediated inhibition of smooth muscle cell proliferation is associated with a late G1 cell cycle arrest , 1993, Journal of cellular physiology.

[13]  H. Koyama,et al.  Regulation of release of hepatocyte growth factor from human promyelocytic leukemia cells, HL-60, by 1,25-dihydroxyvitamin D3, 12-O-tetradecanoylphorbol 13-acetate, and dibutyryl cyclic adenosine monophosphate. , 1993, Blood.

[14]  S. Pang,et al.  Smooth muscle cell proliferation. Expression and kinase activities of p34cdc2 and mitogen-activated protein kinase homologues. , 1993, Circulation research.

[15]  Charles J. Sherr,et al.  Mammalian G1 cyclins , 1993, Cell.

[16]  P. Delafontaine,et al.  Regulation of insulin-like growth factor I receptors on vascular smooth muscle cells by growth factors and phorbol esters. , 1993, Circulation research.

[17]  K. Tanaka,et al.  Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vitro and in vivo. , 1993, Cancer research.

[18]  N. Copeland,et al.  Molecular cloning of a diverged homeobox gene that is rapidly down-regulated during the G0/G1 transition in vascular smooth muscle cells. , 1993, Molecular and cellular biology.

[19]  R. Ross.  The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[20]  C. Heldin,et al.  Structural and functional studies on platelet‐derived growth factor. , 1992, The EMBO journal.

[21]  A. L. Cahill,et al.  Nicotinic Agonists, Phorbol Esters, and Growth Factors Activate Two Extracellular Signal‐Regulated Kinases, ERK1 and ERK2, in Bovine Chromaffin Cells , 1992, Journal of neurochemistry.

[22]  Y. Xiong,et al.  Growth-regulated expression of D-type cyclin genes in human diploid fibroblasts. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[23]  K. Reiss,et al.  Cyclin D1 messenger RNA is inducible by platelet-derived growth factor in cultured fibroblasts. , 1992, Cancer research.

[24]  C. Desgranges,et al.  Cell cycle dependent gene expression in quiescent stimulated and asynchronously cycling arterial smooth muscle cells in culture , 1992, Journal of cellular physiology.

[25]  M. Reidy,et al.  Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF , 1991, Science.

[26]  D. Ingber,et al.  Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth , 1990, Nature.

[27]  A. Gown,et al.  Localization of PDGF-B protein in macrophages in all phases of atherogenesis. , 1990, Science.

[28]  G. King,et al.  Characterization of Induction of Protooncogene c-myc and Cellular Growth in Human Vascular Smooth Muscle Cells by Insulin and IGF-I , 1989, Diabetes.

[29]  Kathleen M. Smith,et al.  Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. , 1988, The Journal of clinical investigation.

[30]  G. Owens,et al.  Cell cycle versus density dependence of smooth muscle alpha actin expression in cultured rat aortic smooth muscle cells , 1988, The Journal of cell biology.

[31]  T. Sturgill,et al.  Insulin-stimulated microtubule-associated protein kinase is phosphorylated on tyrosine and threonine in vivo. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[32]  E. Nishida,et al.  Activation of a Ca2+-inhibitable protein kinase that phosphorylates microtubule-associated protein 2 in vitro by growth factors, phorbol esters, and serum in quiescent cultured human fibroblasts. , 1988, The Journal of biological chemistry.

[33]  T. Barrett,et al.  Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[34]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[35]  R. Ross,et al.  The biology of platelet-derived growth factor , 1986, Cell.

[36]  D. Clemmons,et al.  Evidence for a functional role of endogenously produced somatomedinlike peptides in the regulation of DNA synthesis in cultured human fibroblasts and porcine smooth muscle cells. , 1985, The Journal of clinical investigation.

[37]  C. Kahn,et al.  Receptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta. , 1985, The Journal of clinical investigation.

[38]  Gary R. Grotendorst,et al.  Platelet‐derived growth factor is a chemoattractant for vascular smooth muscle cells , 1982, Journal of cellular physiology.

[39]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[40]  R. Ross.  The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers. , 1971 .

[41]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.